Gilead Sciences EVP sells $557,809 in company stock
On November 6, 2026, Keeley M. Cain Wettan, EVP, General Counsel, Legal & Compliance at Gilead Sciences (NASDAQ: GILD), divested 3,399 shares of the company's stock, generating a total of $557,809. The sale was conducted according to a Rule 10b5-1 trading plan Cain Wettan established on August 7, 2026. She now directly owns 5,360 shares of Gilead Sciences common stock.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
